• Lung Monitoring
  • Our Technology
  • Studies
    • Studies
    • Published Articles
  • About Us
    • About Us
    • Board
    • Management
    • Collaborations
    • Career
  • News
    • Articles and Posts
      • 2018 – 2024
      • 2025 – 2026
    • Press Releases
  • Lung Monitoring
  • Our technology
  • Studies
    • Studies
    • Published Articles
  • About Us
    • About Us
    • Board
    • Management
    • Collaborations
    • Career
  • News
    • Press Releases
    • Articles and posts 2025 –
    • Articles and posts 2018 – 2024
  • Investors
    • Risks and Uncertainties
    • Investor Letters
    • Investor Relations
    • Presentations
    • Reports and Financial Calendar
  • Stock information
    • Stock Information
    • Right Issues
    • Certified Adviser
  • Corporate Governance
    • Corporate Governance
    • Annual General Meetings
Investors

Neola Medical Q3 Report 2024 – Intensifying preparations for the first pivotal clinical study on preterm born babies in the U.S. to secure market approval by the FDA

Nov 6, 2024

Neola Medical is entering the clinical validation phase and is making significant strides toward securing market approval in the U.S., for continuous lung monitoring device, Neola®. The company’s competitive position is strengthened, highlighted by the...

Neola Medical Q2 Report 2024 – Key milestones meet partial regulatory requirements for FDA approval

Aug 15, 2024

Neola Medical reached several critical milestones aligned with its business strategy, aimed at market approval by the FDA. The Human Factors Validation Study with Neola®, was successfully concluded with neonatal nurses in the USA, and will lay a foundation for the...

Neola Medical Q1 rapport 2024 – Framgångsrik studie i USA inför regulatoriskt godkännande av Neola®

May 22, 2024

Det första kvartalet 2024 inleds med förstärkt kassa efter ett starkt avslut på fjolåret med en genomförd riktad nyemission till en premium på aktiekursen, flera uppnådda milstolpar samt framgångsrika slutresultat av...

Neola Medical Bokslutskommuniké 2023 – Med stärkt kassa levereras ännu ett styrkebesked genom patentskydd för kommande lönsamhetsdrivare

Feb 14, 2024

Neola Medical lägger under kvartalet grunden för kommande kommersiella lansering av sin medicinteknik för lungövervakning med start av dotterbolag i USA. Med ett nytt strategiskt patent för Bolagets engångsartiklar ges även ett...

Neola Medical Q3 rapport 2023 – Dörrarna öppnas i USA med stöd från Stanford och nya starka slutresultat från oberoende klinisk studie på nyfödda barn

Nov 9, 2023

Nya framgångsrika resultat från den avslutade oberoende kliniska studien på Irland visar att Neola® mäter syrgas i lungorna hos 100% av de deltagande 100 nyfödda barnen. Vidare bekräftas att teknologin är säker att...
« Older Entries
Next Entries »

Subscribe

Neola Medical AB (publ), founded in 2016 in Lund, Sweden, aims to advance neonatal intensive care with Neola®—a medical device designed for continuous lung monitoring and real-time alerts of potentially life-threatening complications.

Sweden, HQ

Neola Medical AB
Ideon Gateway
Scheelevägen 27
223 63 Lund
info@neolamedical.com

U.S. Office

Neola Medical, Inc.
Nordic Innovation House
470 Ramona Street PMB
Palo Alto CA 94301-1707
info@neolamedical.com

Legal

Cookies
Personal data policy

Social Media
  • Follow
  • Follow
  • Follow

© Neola Medical AB (publ) 2026

Site logo
Privacy Preferences
×

This website uses cookies to enhance your experience. Some are essential for site functionality, while others help us analyze and improve your usage experience. Please review your options and make your choice.

If you are under 16 years old, please ensure that you have received consent from your parent or guardian for any non-essential cookies.

Your privacy is important to us. You can adjust your cookie settings at any time. For more information about how we use data, please read our privacy policy. You may change your preferences at any time by clicking on the settings button below.

Note that if you choose to disable some types of cookies, it may impact your experience of the site and the services we are able to offer.

Essential cookies and services enable basic functions and are necessary for the proper functioning of the website. These cookies and services do not require user permission according to GDPR.
Show details
cookie_notice_accepted
cookies_and_content_security_policy
et-editor-available-post-*
et-pb-recent-items-colors
et-pb-recent-items-font_family
mhcookie
wordpress_logged_in_*
wordpress_test_cookie
wp-settings-*
wp-settings-time-*
neolamedical.com
www.neolamedical.com
Statistics cookies collect usage information, enabling us to gain insights into how our visitors interact with our website.
Show details
_ga (kept for: at least one session)
_ga_* (kept for: at least one session)
_gat_gtag_ua_* (kept for: at least one session)
_gid (kept for: at least one session)
sajssdk_2015_cross_new_user (kept for: at least one session)
region1.google-analytics.com
www.google-analytics.com
www.googletagmanager.com
These cookies and services are necessary to display certain media elements, such as embedded videos, maps, social media posts, etc.
Show details
fast.wistia.net
secure.gravatar.com
www.youtube.com
This category includes all cookies, domains, and services that do not fall into the other specified categories or have not been explicitly categorized.
Show details
amp_* (kept for: at least one session)
cookiesEnabled (kept for: at least one session)
et-editing-post-* (kept for: at least one session)
et-recommend-sync-post-* (kept for: at least one session)
et-saved-post* (kept for: at least one session)
i18next (kept for: at least one session)
proof-of-work (kept for: at least one session)
sensorsdata2015jssdkcross (kept for: at least one session)
ssm_au_c (kept for: at least one session)
dummyimage.com
i.ytimg.com
mb.cision.com
o745714.ingest.sentry.io
picsum.photos
widget.datablocks.se
www.neolamedical.se
Consent date:
Device id:
Accept All Accept Required Only Save Preferences
Privacy Policy

Some required resources have been blocked, which can affect third-party services and may cause the site to not function properly.

Allow all required resources Allow all cookies and services